0000905718-18-000532.txt : 20180518 0000905718-18-000532.hdr.sgml : 20180518 20180518164615 ACCESSION NUMBER: 0000905718-18-000532 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180518 DATE AS OF CHANGE: 20180518 EFFECTIVENESS DATE: 20180518 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Zomedica Pharmaceuticals Corp. CENTRAL INDEX KEY: 0001684144 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-312817 FILM NUMBER: 18847253 BUSINESS ADDRESS: STREET 1: 100 PHOENIX DRIVE STREET 2: SUITE 190 CITY: ANN ARBOR STATE: MI ZIP: 48108 BUSINESS PHONE: (734) 369-2555 MAIL ADDRESS: STREET 1: 100 PHOENIX DRIVE STREET 2: SUITE 190 CITY: ANN ARBOR STATE: MI ZIP: 48108 D 1 primary_doc.xml X0708 D LIVE 0001684144 Zomedica Pharmaceuticals Corp. 100 PHOENIX DRIVE, SUITE 190 ANN ARBOR MI MICHIGAN 48108 (734) 369-2555 ALBERTA, CANADA Wise Oakwood Ventures Inc. None Corporation true 2013 Gerald Solensky 100 Phoenix Drive, Suite 190 Ann Arbor MI MICHIGAN 48108 Executive Officer Director Bruk Herbst 100 Phoenix Drive, Suite 190 Ann Arbor MI MICHIGAN 48108 Executive Officer James Le Bar 100 Phoenix Drive, Suite 190 Ann Arbor MI MICHIGAN 48108 Director Stephanie Morley 100 Phoenix Drive, Suite 190 Ann Arbor MI MICHIGAN 48108 Executive Officer Shameze Rampertab 100 Phoenix Drive, Suite 190 Ann Arbor MI MICHIGAN 48108 Executive Officer Director Jeffrey Rowe 100 Phoenix Drive, Suite 190 Ann Arbor MI MICHIGAN 48108 Director Rodney J. Williams 100 Phoenix Drive, Suite 190 Ann Arbor MI MICHIGAN 48108 Director Thomas Robitaille 100 Phoenix Drive, Suite 190 Ann Arbor MI MICHIGAN 48108 Director Jane Eagleson 100 Phoenix Drive, Suite 190 Ann Arbor MI MICHIGAN 48108 Director Robert DiMarzo 100 Phoenix Drive, Suite 190 Ann Arbor MI MICHIGAN 48108 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2018-05-15 false true false 0 10000000 550000 9450000 false 3 0 0 0 true Some of the proceeds may be used for general working capital purposes, including the payment of salaries and other fees to those listed in Item 3. false Zomedica Pharmaceuticals Corp. /s/ Gerald Solensky Gerald Solensky President & Chief Executive Officer 2018-05-18